Leukocyte count and leukocyte ecto-nucleotidase are major determinants of the effects of adenosine triphosphate and adenosine diphosphate on platelet aggregation in human blood

References

• Puri RN, Colman RW. ADP-induced platelet activation. Crit Rev Biochem Mol 1997;32:437–502.
   PubMed Web of Science ®Google Scholar
• Cattaneo M, Gachet C. ADP receptors and clinical bleeding disorders. Arterioscler Thromb Vasc Biol 1999;19:2281–2285.
   PubMed Web of Science ®Google Scholar
• Holmsen H. Platelet metabolism and activation. Semin Hematol 1985;22:219–240.
   PubMed Web of Science ®Google Scholar
• Jin J, Daniel JL, Kunapuli SP. Molecular basis for ADP-induced platelet activation II. The P2Y₁ receptor mediates ADP-induced intracellular calcium mobilization and shape change in platelets. J Biol Chem 1998;273:2030–2034.
   Google Scholar
• Kunapuli SP. Functional characterization of platelet ADP receptors. Platelets 1998;9:343–351.
   PubMed Web of Science ®Google Scholar
• Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001;86:222–232.
   PubMed Web of Science ®Google Scholar
• Kunapuli SP, Dorsam RT, Kim S, Quinton TM. Platelet purinergic receptors. Curr Opin Pharmacol 2003;3:175–180.
   PubMed Web of Science ®Google Scholar
• Born G. Aggregation of blood platelets by adenosine dipho- sphate and its reversal. Nature 1962;194:927–929.
   PubMed Web of Science ®Google Scholar
• Fox SC, Burgess-Wilson M, Heptinstall S, Mitchell JRA. Platelet aggregation in whole blood determined using the Ultra-Flo 100 platelet counter. Thromb Haemost 1982;48:327–329.
   PubMed Web of Science ®Google Scholar
• Storey RF, Heptinstall S. Laboratory investigation of platelet function. Clin Lab Haematol 1999;21:317–329.
   PubMedGoogle Scholar
• Rao AK. Inherited defects in platelet signaling mechanisms. J Thromb Haemost 2003;1:671–681.
   PubMedGoogle Scholar
• Ingall AH, Dixon J, Bailey A, Coombs ME, Cox D, McInally JI, Hunt SF, Kindon ND, Teobald BJ, Willis PA, Humphries RG, Leff P, Clegg JA, Smith JA, Tomlinson W. Antagonists of the platelet P2T receptor: A novel approach to antithrombotic therapy. J Med Chem 1999;42:213–220.
   PubMed Web of Science ®Google Scholar
• Storey RF, Sanderson HM, White AE, May JA, Cameron KE, Heptinstall S. The central role of the P2T receptor in amplification of human platelet activation, aggregation, secretion and procoagulant activity. Br J Haematol 2000;110:925–934.
   PubMed Web of Science ®Google Scholar
• Baurand A, Raboisson P, Freund M, Leon C, Cazenave JP, Bourguignon JJ, Gachet C. Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist. Eur J Pharmacol 2001;412:213–221.
   PubMed Web of Science ®Google Scholar
• Storey RF, Wilcox RG, Heptinstall S. Comparison of the pharmacodynamic effects of the platelet ADP receptor antagonists clopidogrel and AR-C69931MX in patients with ischaemic heart disease. Platelets 2002;13:407–413.
   PubMed Web of Science ®Google Scholar
• Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP. The effects of clopidogrel, aspirin and both antiplatelet agents on platelet function in patients with peripheral arterial disease. Platelets 2004;15:117–125.
   PubMed Web of Science ®Google Scholar
• Heptinstall S. The importance of platelet aggregation in coronary disease. Br J Cardiol 2000;7(Suppl 1):S27–S30.
   Google Scholar
• Cannon CP. Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial). Am J Cardiol 2002;90:760–762.
   PubMed Web of Science ®Google Scholar
• Chopra V, Marmur JD, Cavusoglu E. The role of clopidogrel in the management of patients with ischemic heart disease. Cardiovasc Drug Ther 2003;17:467–477.
   PubMed Web of Science ®Google Scholar
• Ho WK, Hankey GJ, Eikelboom JW. Prevention of coronary heart disease with aspirin and clopidogrel: efficacy, safety, cost and cost-effectiveness. Expert Opin Pharmacol 2004;5:493–503.
   Google Scholar
• Di Virgilio F, Chiozzy P, Ferrari D, Falzoni S, Sanz JM, Morelly A, Torboli M, Bolognesi G, Baricordi R. Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 2001;97:587–600.
   PubMed Web of Science ®Google Scholar
• Geigy JR. Physical chemistry, composition of blood, hematol- ogy, somatometric data. In: Scientific tables. 8th ed. Vol 3. Basle: Ciba-Geigy; 1984. p 104.
   Google Scholar
• Soslau G, Youngprapakorn D. A possible dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochim Biophys Acta-Mol Cell Res 1997;1355:131–140.
   PubMed Web of Science ®Google Scholar
• Hechler B, Vigne P, Leon C, Breittmayer JP, Gachet C, Frelin C. ATP derivatives are antagonists of the P2Y1 receptor: similarities to the platelet ADP receptor. Mol Pharmacol 1998;53:727–733.
   PubMed Web of Science ®Google Scholar
• Hourani SMO. Discovery and recognition of purine receptor subtypes on platelets. Drug Dev Res 2001;52:140–149.
   Google Scholar
• Nicholas RA. Identification of the P2Y12 receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol Pharmacol 2001;60:416–420.
   PubMed Web of Science ®Google Scholar
• Stafford NP, Pink AE, White AE, Glenn JR, Heptinstall S. Mechanisms involved in adenosine triphosphate-induced platelet aggregation in whole blood. Arterioscler Thromb Vasc Biol 2003;23:1928–1933.
   PubMed Web of Science ®Google Scholar
• Kroll MH, Schafer AI. Biochemical mechanisms of platelet activation. Blood 1989;74:1181–1195.
   PubMed Web of Science ®Google Scholar
• Fox SC, Sasae R, Janson S, May JA, Heptinstall S. Quantitation of platelet aggregation and microaggregate formation in whole blood by flow cytometry. Platelets 2004;15:85–93.
   PubMed Web of Science ®Google Scholar
• Teerlink T, Hennekes M, Bussemaker J, Groeneveld J. Simultaneous determination of creatine compounds and adenine nucleotides in myocardial tissue by high performance liquid chromatography. Anal Biochem 1993;214:278–283.
   PubMed Web of Science ®Google Scholar
• Zimmermann H. Extracellular metabolism of ATP and other nucleotides. Naunyn-Schmiedeberg’s Arch Pharmacol 2000;362:299–309.
   Google Scholar
• Smith GP, Peters, TJ. Subcellular localization and properties of adenosine diphosphatase activity in human polymorpho- nuclear leukocytes. Biochim Biophys Acta 1981;673:234–242.
   PubMed Web of Science ®Google Scholar
• Coade SB, Pearson JD. Metabolism of adenine nucleotides in human blood. Circ Res 1989;65:531–537.
   PubMed Web of Science ®Google Scholar
• Kansas GS, Wood GS, Tedder TF. Expression, distribution and biochemistry of human CD39. Role in activation- associated homotypic adhesion of lymphocytes. J Immunol 1991;146:2235–2244.
   Google Scholar
• Beukers MW, Pirovano IM, van Weert A, Kerkhof CJM, Ijzerman AP, Soudijn W. Characterization of ecto-ATPase on human blood cells: a physiological role in platelet aggregation. Biochem Pharmocol 1993;46:1959–1966.
   PubMedGoogle Scholar
• Plesner L. Ecto-ATPases: identities and functions. Int Rev Cytol 1995;158:141–214.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Okada T, Garcia del Saz E, Seguchi H. Internalization of exto-ATPase activity in human neutrophils upon stimulation with phorbol ester or formyl pepride. Histochem Cell Biol 1997;107:353–363.
   Google Scholar
• Koziak K, Se´vigny J, Robson SC, Siegel JB, Kaczmarek E. Analysis of CD39/ATP diphosphohydrolases (ATPDase) expression in endothelial cells, platelets and leukocytes. Thromb Haemost 1999;82:1538–1544.
   PubMed Web of Science ®Google Scholar
• Langston PH, Ke Y, Gewirtz AT, Dombrowski KE, Kapp JA. Secretion of IL-2 and IFN-g, but not IL-4, by antigen-specific T cells requires extracellular ATP. J Immunol 2003;170:2962–2970.
   PubMed Web of Science ®Google Scholar
• Leukocyte typing V: White cell differentiation antigens. Vol. 1. London: Oxford University Press; 1995. p 91.
   Google Scholar
• Marcus AJ, Broekman MJ, Drosophoulous JHF, Islam N, Pinsky DJ, Sesti C, Levi R. Metabolic control of excessive extracellular nucleotide accumulation by CD39/ecto-nucleo- tidase-1: Implications for ischemic vascular diseases. J Pharmacol Exp Ther 2003;305:9–16.
   PubMed Web of Science ®Google Scholar
• Salvemini D, De Nucci G, Gryglewski RJ, Vane JR. Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor. Proc Natl Acad Sci USA 1989;86:6328–6332.
   PubMed Web of Science ®Google Scholar
• Nicolini FA, Wilson AC, Mehta P, Mehta JL. Comparative platelet inhibitory effects of human neutrophils and lympho- cytes. J Lab Clin Med 1990;116;147-151.
   Google Scholar
• Zatta A, Prosdocimi M, Bertele V, Bazzoni G, Del Maschio A. Inhibition of platelet function by polymorphonuclear leuko- cytes. J Lab Clin Med 1990;116:651–659.
   PubMed Web of Science ®Google Scholar
• Valles J, Santos MT, Marcus AJ, Safier LB, Broekman MJ, Islam N, Ullman HL, Aznar J. Downregulation of human platelet reactivity by neutrophils. J Clin Invest 1993;92:1357–1365.
   PubMed Web of Science ®Google Scholar
• Pilla A, Emanuelli T, Frassetto SS, Battastini AMO, Dias RD, Sarkis JJF. ATP diphosphohyrdolase activity (apyrase, EC 3.6.1.5) in human blood platelets. Platelets 1996;7:225–230.
   Google Scholar
• Rossatto ER, da Silva LB, Pereira GS, Bonan CD, Battastini JP, Ribeiro JP, Sarkis JJF. ATP diphosphohydrolase in human platelets from patients with coronary arteries heart disease. Platelets 2003;14:47–52.
   PubMed Web of Science ®Google Scholar
• Birk AV, Broekman MJ, Gladek EM, Robertson HD, Drosopoulos JHF, Marcus AJ, Szeto HH. Role of extracellular ATP metabolism in regulation of platelet reactivity. J Lab Clin Med 2002;140:166–175.
   PubMed Web of Science ®Google Scholar
• Chen W, Guidotti G. Soluble apyrases release ADP during ATP hydrolysis. Biochem Biophys Res Commun 2001;282:90–95.
   PubMedGoogle Scholar
• Se´vigny J, Sundberg C, Braun N, Guckelberger O, Csizmadia E, Qawi I, Imai M, Zimmermann H, Robson SC. Differential catalytic properties and vascular topography of murine nucleoside triphosphate diphosphohydrolase 1 (NTPDase1) and NTPDase2 have implications for thromboregulation. Blood 2002;99:2801–2809.
   PubMed Web of Science ®Google Scholar